Where should the Depo‑Provera (medroxyprogesterone acetate) injection be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Depo-Provera Injection Site

Depo-Provera (medroxyprogesterone acetate) 150 mg should be administered by deep intramuscular injection into either the gluteal or deltoid muscle, rotating sites with every injection. 1

Administration Details

The FDA-approved prescribing information is explicit about proper administration technique 1:

  • Approved sites: Gluteal muscle OR deltoid muscle
  • Route: Deep intramuscular (IM) injection
  • Technique: Use strict aseptic technique
  • Dose: 150 mg every 3 months (13 weeks)
  • Important: Vigorously shake the vial or prefilled syringe just before use to ensure uniform suspension

Critical Technical Considerations

Body habitus assessment is essential before each injection. As with any IM injection, you must assess the patient's body composition prior to injection to determine if a longer needle is necessary, particularly for gluteal IM injection, to avoid inadvertent subcutaneous administration 1. The standard prefilled syringes come with 22-gauge x 1½ inch needles 1.

Site rotation is mandatory - alternate between gluteal and deltoid muscles with each subsequent injection to minimize local tissue reactions 1.

Subcutaneous Formulation Alternative

A distinct lower-dose subcutaneous formulation exists (Depo-SubQ Provera 104 mg), which is administered subcutaneously in the anterior thigh or abdomen 2, 3. Recent research demonstrates that the upper arm is also an effective subcutaneous injection site for the 104 mg formulation 3, 4. However, this is a different product with different dosing (104 mg vs 150 mg) and should not be confused with the standard intramuscular Depo-Provera.

Common Pitfall to Avoid

Do not administer the 150 mg intramuscular formulation subcutaneously. While research has explored subcutaneous administration of the 150 mg dose 5, this is not FDA-approved and the standard 150 mg Depo-Provera Contraceptive Injection must be given intramuscularly as labeled 1. Using the wrong route could result in suboptimal contraceptive efficacy.

The buttock (gluteal) and upper arm (deltoid) remain the only two FDA-approved intramuscular injection sites for standard Depo-Provera 150 mg 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.